HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 2 filers reported holding HARPOON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $26,741 | -32.1% | 37,663 | -28.9% | 0.00% | – |
| Q1 2023 | $39,404 | +2.5% | 52,947 | -0.1% | 0.00% | – |
| Q4 2022 | $38,457 | -26.0% | 52,992 | 0.0% | 0.00% | – |
| Q3 2022 | $52,000 | -48.5% | 52,992 | 0.0% | 0.00% | – |
| Q2 2022 | $101,000 | -89.0% | 52,992 | -71.3% | 0.00% | – |
| Q1 2022 | $916,000 | -36.5% | 184,362 | -3.6% | 0.00% | – |
| Q4 2021 | $1,443,000 | -7.8% | 191,251 | -3.4% | 0.00% | – |
| Q3 2021 | $1,565,000 | -46.1% | 198,059 | -5.4% | 0.00% | -100.0% |
| Q2 2021 | $2,904,000 | -22.3% | 209,369 | +17.2% | 0.00% | 0.0% |
| Q1 2021 | $3,739,000 | +42.9% | 178,712 | +13.4% | 0.00% | 0.0% |
| Q4 2020 | $2,617,000 | -5.8% | 157,576 | -3.6% | 0.00% | 0.0% |
| Q3 2020 | $2,778,000 | +10.0% | 163,446 | +7.5% | 0.00% | 0.0% |
| Q2 2020 | $2,525,000 | +141.9% | 152,055 | +68.4% | 0.00% | – |
| Q1 2020 | $1,044,000 | -12.4% | 90,278 | +12.0% | 0.00% | – |
| Q4 2019 | $1,192,000 | +1.6% | 80,592 | -6.1% | 0.00% | – |
| Q3 2019 | $1,173,000 | +152.3% | 85,839 | +140.1% | 0.00% | – |
| Q2 2019 | $465,000 | +50.5% | 35,745 | +9.4% | 0.00% | – |
| Q1 2019 | $309,000 | – | 32,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,130,267 | $43,417,000 | 8.07% |
| MPM BioImpact LLC | 3,196,707 | $44,338,000 | 7.28% |
| Aquilo Capital Management, LLC | 712,674 | $9,885,000 | 2.57% |
| Logos Global Management LP | 800,000 | $11,096,000 | 0.93% |
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $3,364,000 | 0.86% |
| VR Adviser, LLC | 512,005 | $7,102,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 580,759 | $8,055,000 | 0.65% |
| Avidity Partners Management LP | 1,500,000 | $20,805,000 | 0.56% |
| Orbimed Advisors | 2,611,308 | $36,219,000 | 0.37% |
| Maven Securities LTD | 618,610 | $8,456,000 | 0.34% |